BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32373978)

  • 1. MiRNA-584 suppresses the progression of NK/T-cell lymphoma by targeting FOXO1.
    Wang CC; Han L; Hou YH; Ying XY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4404-4411. PubMed ID: 32373978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene.
    Ji WG; Zhang XD; Sun XD; Wang XQ; Chang BP; Zhang MZ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):882-888. PubMed ID: 25480585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.
    Yang N; Zhang Q; Bi XJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):65-73. PubMed ID: 31957819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
    Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-203a-5p alleviates the malignant progression of Wilms' tumor via targeting JAG1.
    Bao JW; Li WJ; Guo JH; Lv ZB; Whang Z
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5329-5335. PubMed ID: 32495866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-223 suppresses FOXO1 and functions as a potential tumor marker in breast cancer.
    Wei YT; Guo DW; Hou XZ; Jiang DQ
    Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):113-118. PubMed ID: 28719355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA AK024094 aggravates the progression of breast cancer through regulating miRNA-181a.
    Zheng TZ; Li YT; Li WJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1913-1921. PubMed ID: 32141560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.
    Yang L; Ma HL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1062-1071. PubMed ID: 32096176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-96 regulates pancreatic β cell function under the pathological condition of diabetes mellitus through targeting Foxo1 and Sox6.
    Qi H; Yao L; Liu Q
    Biochem Biophys Res Commun; 2019 Nov; 519(2):294-301. PubMed ID: 31506178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene.
    Yu J; Ni Q; Zhang S; Hua R; Tao R; Tang C; Feng S
    Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):95-100. PubMed ID: 32359391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MiR-30b Regulates the Cisplatin-Resistance of Human NK/T Cell Lypnphoma Cell Lines SNK-6 and YTS by Targeting the CCL22].
    Wang JH; Liu F; Duan XH; Hao CX; Liu XX; Lu YJ; Wang Z; Liang R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1838-1844. PubMed ID: 31839047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
    Sun D; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation.
    Xuan J; Huang A; Hu D; Geng J; Tian Y; Cheng Z; Qiu Y
    Exp Mol Pathol; 2020 Aug; 115():104447. PubMed ID: 32380055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-206 suppresses the metastasis of osteosarcoma via targeting Notch3.
    Cai WT; Guan P; Lin MX; Fu B; Wu B; Wu J
    J Biol Regul Homeost Agents; 2020; 34(3):775-783. PubMed ID: 32627519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
    Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335.
    Wang WJ; Sun K; Li FY; Hui XB; Liu D; Liu J; Wang XD
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):758-765. PubMed ID: 32016979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level.
    Li SS; Zhu HJ; Li JY; Tian LM; Lv DM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1126-1133. PubMed ID: 32096168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.
    Moriai S; Takahara M; Ogino T; Nagato T; Kishibe K; Ishii H; Katayama A; Shimizu N; Harabuchi Y
    Clin Cancer Res; 2009 Nov; 15(22):6771-9. PubMed ID: 19887486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exploration of the Role of Tumor Suppressor Genes Foxo1 and PTEN in the Tumorigenesis of Mouse Natural Killer-Cell Lymphoma].
    Jiang Y; Liao HY; Yang QS; Chen Y; Hu YN; Yuan SZ; Su SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):439-444. PubMed ID: 30998151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.